Is SDEV or SER more undervalued in 2026?

CirclFi compares Stablecoin Development Corporat (SDEV) and Serina Therapeutics, Inc. (SER) using 13 institutional-grade valuation models. SDEV has a Quality of Company score of 4.2/10 while SER scores 4.9/10.

Which is a better buy — SDEV or SER?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do SDEV and SER valuations compare?

SDEV at $1.27 and SER at $1.84 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

SDEV vs SER Valuation Comparison 2026 — Intrinsic Value Analysis

SDEV

Pharmaceutical Preparations

Stablecoin Development Corporat

Quality

4.2

out of 10

Value Trap

LOW

Price

$1.27

Last close

Models

10/13

Active

SER

Pharmaceutical Preparations

Serina Therapeutics, Inc.

Quality

4.9

out of 10

Value Trap

LOW

Price

$1.84

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	SDEV Fair Value	SDEV Upside	SER Fair Value	SER Upside
Bayesian DCF	Intrinsic	$0.81	-36.1%	$1.12	-39.3%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$2.20	+73.2%	$2.49	+35.4%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for SDEV vs SER — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

SDEV vs SER — Which Stock Is More Undervalued?

SER scores higher with a 4.9/10 quality rating vs SDEV's 4.2/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Stablecoin Development Corporat (SDEV) and Serina Therapeutics, Inc. (SER) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

SDEV currently trades at $1.27 with a QOC of 4.2/10, while SER trades at $1.84 with a QOC of 4.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).